Cited by 271Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease PreventionIron Metabolism and Disorders

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease

Open access

Duffy, Stephen J., Biegelsen, Elizabeth S., Holbrook, Monika, Russell, Judson D., Gokce, Noyan, Keaney, John F., Vita, Joseph A.·2001·Circulation

DOI 10.1161/01.cir.103.23.2799

Open this paper in CoChat — free account Open PDF

Abstract

Background —Some epidemiological studies have shown that increased iron stores are associated with increased cardiovascular events. Redox-active iron may contribute to lipid peroxidation, endothelial cell activation, and generation of reactive oxygen species (especially hydroxyl radical, via Fenton chemistry). Increased oxidative stress is associated with impaired action of endothelium-derived nitric oxide in patients with atherosclerosis. Methods and Results —To test the hypothesis that reducing vascular iron stores would reverse endothelial dysfunction, we examined the effects of the iron chelator deferoxamine (500 mg intra-arterially over 1 hour) on vasomotor function in forearm resistance vessels of patients with coronary artery disease by venous occlusion plethysmography. Patients with coronary artery disease had impaired endothelium-dependent vasodilation in response to methacholine compared with healthy control subjects ( P <0.001). Deferoxamine infusion decreased serum iron levels ( P <0.001). Deferoxamine improved the blood flow response to methacholine in patients with coronary artery disease ( P <0.01 by 2-way repeated-measures ANOVA) but had no effect on the response to sodium nitroprusside. In normal volunteers, deferoxamine had no effect on the response to methacholine. The nitric oxide synthase inhibitor N G -monomethyl- l -arginine abolished augmentation of the methacholine response associated with deferoxamine. The hydroxyl radical scavenger mannitol had no effect on the methacholine response. Conclusions —Deferoxamine improved nitric oxide–mediated, endothelium-dependent vasodilation in patients with coronary artery disease. These results suggest that iron availability contributes to impaired nitric oxide action in atherosclerosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.103.23.2799

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742
Antioxidants and Atherosclerotic Heart Disease
Diaz, M. N., Frei, B. B., Vita, J. A., & Keaney, J. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370607 · Cited by 1,353
Self-citation
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
Salonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., & Salonen, R. (1992) · Circulation · doi:10.1161/01.cir.86.3.803 · Cited by 1,284
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,172
Self-citation
Oxidative Stress as a Regulator of Gene Expression in the Vasculature
KUNSCH, C. A., & Medford, R. M. (1999) · Circulation Research · doi:10.1161/01.res.85.8.753 · Cited by 801
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
Williams, S. B., Goldfine, A. B., Timimi, F. K., Ting, H. H., Roddy, M.-A., Simonson, D. C., & Creager, M. A. (1998) · Circulation · doi:10.1161/01.cir.97.17.1695 · Cited by 793
Nitric oxide and iron proteins
Cooper, C. E. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00021-3 · Cited by 510
Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
Smith, C., Mitchinson, M. J., Aruoma, O. I., & Halliwell, B. (1992) · Biochemical Journal · doi:10.1042/bj2860901 · Cited by 455

Show all 34 references

Research works printed but not linked: 14

10.1161/circ.86.3.1516192 · DOI
10.1161/circ.100.12.1268 · DOI
10.1161/circ.89.3.8124837 · DOI
10.1161/circ.96.10.3300 · DOI
10.1161/circ.99.9.1222 · DOI
10.1161/circ.99.7.852 · DOI
10.1161/res.85.8.753 · DOI
10.1161/circ.99.24.3118 · DOI
10.1161/circ.81.2.2105174 · DOI
10.1161/circ.97.8.736 · DOI
10.1161/hyp.35.4.936 · DOI
10.1161/circ.100.19.1951 · DOI
10.1161/circ.51.6.1132099 · DOI
10.1161/circ.97.17.1695 · DOI

Sorted by citations

The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Self-citation
Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases
Yu, Y., Yan, Y., Niu, F., Wang, Y., Chen, X., Su, G., Liu, Y., Zhao, X., Lü, Q., Liu, P., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00579-w · Cited by 808
Absorption and metabolism of polyphenols in the gut and impact on health.
Scalbert, A., Morand, C., Manach, C., & Rémésy, C. (2002) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/s0753-3322(02)00205-6 · Cited by 712
Cross-Talk Between Iron Metabolism and Diabetes
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2348 · Cited by 704
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study
Sarnak, M. J., Tighiouart, H., Manjunath, G., MacLeod, B., Griffith, J. L., Salem, D. N., & Levey, A. S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01938-1 · Cited by 513
A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance
Tanner, M. A., Galanello, R., Dessì, C., Smith, G. C., Westwood, M. A., Agus, A., Roughton, M., Assomull, R., Nair, S. V., Walker, J. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.648790 · Cited by 480
Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities
Thomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease
Drüeke, T. B., Witko‐Sarsat, V., Massy, Z. A., Descamps‐Latscha, B., Guérin, A. P., Marchais, S. J., Gausson, V., & London, G. M. (2002) · Circulation · doi:10.1161/01.cir.0000035250.66458.67 · Cited by 375
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Blood Letting in High-Ferritin Type 2 Diabetes
Fernández‐Real, J. M., Peñarroja, G., Castro, A., Garcia-Bragado, F., Hernández‐Aguado, I., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1000 · Cited by 340
Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
Stankiewicz, J. M., Panter, S. S., Neema, M., Arora, A., Batt, C. E., & Bakshi, R. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.006 · Cited by 304
Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells
Kotamraju, S., Chitambar, C. R., Kalivendi, S. V., Joseph, J., & Kalyanaraman, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111604200 · Cited by 236
Age Decreases Endothelial Progenitor Cell Recruitment Through Decreases in Hypoxia-Inducible Factor 1α Stabilization During Ischemia
Chang, E. I., Loh, S. A., Ceradini, D. J., Chang, E. I., Lin, S.-E., Bastidas, N., Aarabi, S., Chan, D. A., Freedman, M. L., Giaccia, A. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.715847 · Cited by 206
Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo
Asleh, R., Guetta, J., Kalet-Litman, S., Miller‐Lotan, R., & Levy, A. P. (2005) · Circulation Research · doi:10.1161/01.res.0000156653.05853.b9 · Cited by 202
Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis
Day, S. M., Duquaine, D., Mundada, L. V., Menon, R. G., Khan, B. V., Rajagopalan, S., & Fay, W. P. (2003) · Circulation · doi:10.1161/01.cir.0000066910.02844.d0 · Cited by 192
Iron homeostasis in the metabolic syndrome
Datz, C., Felder, T. K., Niederseer, D., & Aigner, E. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12032 · Cited by 181
Pathological Roles of Iron in Cardiovascular Disease
Kobayashi, M., Suhara, T., Baba, Y., Kawasaki, N. K., Higa, J. K., & Matsui, T. (2018) · Current Drug Targets · doi:10.2174/1389450119666180605112235 · Cited by 182
Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2007) · JAMA · doi:10.1001/jama.297.6.603 · Cited by 180
The molecular mechanisms of ferroptosis and its role in cardiovascular disease
Zhang, Y., Xin, L., Xiang, M., Shang, C., Wang, Y., Wang, Y., Cui, X., & Lu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112423 · Cited by 175
Atherogenesis and iron: from epidemiology to cellular level
Vinchi, F., Muckenthaler, M. U., da Silva, M. C., Balla, G. J., Balla, J., & Jeney, V. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00094 · Cited by 176
Cold ischemic injury of transplanted kidneys: new insights from experimental studies
Salahudeen, A. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00098.2004 · Cited by 166
The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection
Ravíngerová, T., Kindernay, L., Barteková, M., Ferko, M., Adameová, A., Zohdi, V., Bernátová, I., Ferenczyová, K., & Lazou, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217889 · Cited by 169
Oxidative Stress–Induced Iron Signaling Is Responsible for Peroxide-Dependent Oxidation of Dichlorodihydrofluorescein in Endothelial Cells
Tampo, Y., Kotamraju, S., Chitambar, C. R., Kalivendi, S. V., Keszler, Á., Joseph, J., & Kalyanaraman, B. (2003) · Circulation Research · doi:10.1161/01.res.0000048195.15637.ac · Cited by 164
Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
Sawicki, K. T., Jesus, A. D., & Ardehali, H. (2023) · Circulation Research · doi:10.1161/circresaha.122.321667 · Cited by 168
The role of iron neurotoxicity in ischemic stroke
Selim, M. H., & Ratan, R. R. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.04.001 · Cited by 158
Arterial Stiffness and Endothelial Function in Patients With β-Thalassemia Major
Cheung, Y., Chan, G., & Ha, S. (2002) · Circulation · doi:10.1161/01.cir.0000037225.92759.a7 · Cited by 153
Molecular, physiological and clinical aspects of the iron storage protein ferritin
Orino, K., & Watanabe, K. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.07.006 · Cited by 148
Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis
Gaenzer, H., Marschang, P., Sturm, W., Neumayr, G., Vogel, W., Patsch, J. R., & Weiß, G. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02611-6 · Cited by 147
The Role of Oxidative Stress in the Metabolic Syndrome
Whaley‐Connell, A. T., McCullough, P. A., & Sowers, J. R. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0555 · Cited by 146
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Sullivan, J. L. (2007) · Experimental Biology and Medicine · doi:10.3181/0703-mr-54 · Cited by 147
Iron and thrombosis
Franchini, M., Targher, G., Montagnana, M., & Lippi, G. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0416-1 · Cited by 142
The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice
Zhang, W., Hao, W., & Frei, B. B. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009229 · Cited by 117
A Diffusible Substance(s) Mediates Endothelium-Dependent Contractions in the Aorta of SHR
Yang, D., Félétou, M., Levens, N. R., Zhang, J. N., & Vanhoutte, P. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000047651.45322.16 · Cited by 117
Iron Stores and Vascular Function in Voluntary Blood Donors
Zheng, H., Cable, R. G., Spencer, B. R., Votto, N., & Katz, S. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000174126.28201.61 · Cited by 112
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver
Aigner, E. S. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.177 · Cited by 116
Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP)
Wolff, B., Völzke, H., Lüdemann, J., Robinson, D., Vogelgesang, D., Staudt, A., Kessler, C., Dahm, J. B., John, U., & Felix, S. B. (2004) · Stroke · doi:10.1161/01.str.0000114875.31599.1c · Cited by 108
The role of labile iron pool in cardiovascular diseases.
Kruszewski, M. K. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3585 · Cited by 104
The role of hepcidin and iron homeostasis in atherosclerosis
Wunderer, F., Traeger, L., Sigurslid, H. H., Meybohm, P., Bloch, D. B., & Malhotra, R. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104664 · Cited by 109
Iron overload and cardiovascular complications in dialysis patients
Kletzmayr, J., & Hörl, W. H. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_2.25 · Cited by 104
The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit
Minqin, R., Rajendran, R., Pan, N., Kwong-Huat Tan, B., Ong, W.-Y., Watt, F., & Halliwell, B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.008 · Cited by 100
Anemia as a risk factor for cardiovascular disease
Pereira, A. A., & Sarnak, M. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s87.6.x · Cited by 105
Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation–Myocardial Infarction
Chan, W., Taylor, A. J., Ellims, A., Lefkovits, L., Wong, C. Y., Kingwell, B. A., Natoli, A., Croft, K. D., Mori, T. A., Kaye, D. M., et al. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.966226 · Cited by 102
Self-citation
Iron overload in myelodysplastic syndromes (MDS)
Gattermann, N. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2367-1 · Cited by 96
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease
Valenti, L. V. C., Swinkels, D. W., Burdick, L., Dongiovanni, P., Tjalsma, H., Motta, B. M., Bertelli, C., Fatta, E., Bignamini, D., Rametta, R., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.003 · Cited by 93
Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2
Dreger, H., Westphal, K., Wilck, N., Baumann, G., Stangl, V., Stangl, K., & Meiners, S. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp279 · Cited by 92
The relationship between trace elements and cardiac markers in acute coronary syndromes
Altekin, E., Çöker, C., Şişman, A. R., Önvural, B., Kuralay, F., & Kırımlı, Ö. (2005) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2004.12.002 · Cited by 88
Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations
Valenti, L. V. C., Dongiovanni, P., Motta, B. M., Swinkels, D. W., Bonara, P., Rametta, R., Burdick, L., Frugoni, C., Fracanzani, A. L., & Fargion, S. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.214858 · Cited by 88
Tumor Necrosis Factor-α–Induced Iron Sequestration and Oxidative Stress in Human Endothelial Cells
Nanami, M., Ookawara, T., Otaki, Y., Ito, K., Moriguchi, R., Miyagawa, K., Hasuike, Y., Izumi, M., Eguchi, H., Suzuki, K., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190610.63878.20 · Cited by 87
Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing
Duscher, D., Januszyk, M., Maan, Z. N., Whittam, A. J., Hu, M. S.-M., Walmsley, G. G., Dong, Y., Khong, S. M. L., Longaker, M. T., & Gurtner, G. C. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003072 · Cited by 86
Blood Letting in High-Ferritin Type 2 Diabetes
Fernández‐Real, J. M., Peñarroja, G., Castro, A., Garcia-Bragado, F., López‐Bermejo, A., & Ricart, W. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2249 · Cited by 86
Iron, oxidative stress, and redox signaling in the cardiovascular system
Gudjoncik, A., Guénancia, C., Zeller, M., Cottin, Y., Vergely, C., & Rochette, L. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400036 · Cited by 87
Iron and Heart Failure
Ghafourian, K., Shapiro, J. S., Goodman, L., & Ardehali, H. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.009 · Cited by 85
Mechanism of dilation to reactive oxygen species in human coronary arterioles
Sato, A., Sakuma, I., & Gutterman, D. D. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00458.2003 · Cited by 81
Micronutrient (Zn, Cu, Fe)–gene interactions in ageing and inflammatory age-related diseases: Implications for treatments
Mocchegiani, E., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., & Malavolta, M. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.004 · Cited by 83
The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure
Lim, C. S., & Vaziri, N. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00580.x · Cited by 80
The Role of Iron in the Pathogenesis of Atherosclerosis
Kraml, P. (2017) · Physiological Research · doi:10.33549/physiolres.933589 · Cited by 80
Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease
Maiocchi, S. L., Ku, J., Thai, T., Chan, E., Rees, M. D., & Thomas, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107711 · Cited by 78
Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis
Sullivan, J. L. (2003) · American Heart Journal · doi:10.1067/mhj.2003.142 · Cited by 72
Neuropilin-1 Controls Endothelial Homeostasis by Regulating Mitochondrial Function and Iron-Dependent Oxidative Stress
Issitt, T., Bosseboeuf, E., de Winter, N., Dufton, N., Gestri, G., Senatore, V., Chikh, A., RANDI, A. M., & Raimondi, C. (2018) · iScience · doi:10.1016/j.isci.2018.12.005 · Cited by 74
Role of iron in atherosclerosis
Shah, S. V., & Alam, M. G. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50091 · Cited by 72
Endothelial activation and induction of monocyte adhesion by nontransferrin‐bound iron present in human sera
Kartikasari, A. E. R., Georgiou, N., Visseren, F. L. J., Kats-Renaud, H. J. V., van Asbeck, B. S., & Marx, J. J. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4700fje · Cited by 70
Intracellular metal ion chelators inhibit TNFα-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells
Zhang, W. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01375-8 · Cited by 70
Ferroptosis in cardiovascular disease
Liu, G., Xie, X., Liao, W., Chen, S., Zhong, R., Qin, J., He, P., & Xie, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116057 · Cited by 69
Distribution of zinc, copper and iron in biological samples of Pakistani myocardial infarction (1st, 2nd and 3rd heart attack) patients and controls
Kazi, T. G., Afridi, H. I., Kazi, N. G., Jamali, M. K., Arain, M. B., Sarfraz, R. A., Jalbani, N. B., Ansari, R., Shah, A. Q., Memon, A. R., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.12.004 · Cited by 68
Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A
Visseren, F. L. J., Verkerk, M. S. A., Van Der Bruggen, T., Marx, J. J. M., Van Asbeck, B. S., & Diepersloot, R. J. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1084.x · Cited by 64
Secretion of Ferritin by Iron-laden Macrophages and Influence of Lipoproteins
Yuan, X., Li, W., Baird, S. K., Carlsson, M., & Melefors, Ö. (2004) · Free Radical Research · doi:10.1080/10715760400011692 · Cited by 64
Iron-Induced Fibrin in Cardiovascular Disease
Lipiński, B., & Pretorius, E. (2013) · Current Neurovascular Research · doi:10.2174/15672026113109990016 · Cited by 62
Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community
Klip, I. T., Voors, A. A., Swinkels, D. W., Bakker, S. J. L., Kootstra‐Ros, J. E., Lam, C. S. P., van der Harst, P., van Veldhuisen, D. J., & van der Meer, P. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.622 · Cited by 65
Lipocalin 2 regulation by thermal stresses: Protective role of Lcn2/NGAL against cold and heat stresses
Roudkenar, M. H., Halabian, R., Roushandeh, A. M., Nourani, M. R., Masroori, N., Ebrahimi, M., Nikogoftar, M., Rouhbakhsh, M., Bahmani, P., Jahanian‐Najafabadi, A., et al. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.08.019 · Cited by 62
Iron Sucrose Promotes Endothelial Injury and Dysfunction and Monocyte Adhesion/Infiltration
Kamanna, V. S., Ganji, S. H., Shelkovnikov, S., Norris, K. C., & Vaziri, N. D. (2011) · American Journal of Nephrology · doi:10.1159/000334939 · Cited by 62
Low-Renin Hypertension With Relative Aldosterone Excess Is Associated With Impaired NO-Mediated Vasodilation
Duffy, S. J., Biegelsen, E. S., Eberhardt, R. T., Kahn, D. F., Kingwell, B. A., & Vita, J. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000184231.84465.62 · Cited by 60
Self-citation
Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II–Infused Rats
Ishizaka, N., Saito, K., Mori, I., Matsuzaki, G., Ohno, M., & Nagai, R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181763.57495.2b · Cited by 55
Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables
Holsworth, R., Cho, Y. I., Weidman, J. J., Sloop, G. D., & Cyr, J. A. S. (2013) · Perfusion · doi:10.1177/0267659113505637 · Cited by 61
Iron in Cardiovascular Disease: Challenges and Potentials
Li, S., & Zhang, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707138 · Cited by 57
Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Ramakrishna, G., Rooke, T. W., & Cooper, L. T. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm493ra · Cited by 54
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload
Bi, Y., Ajoolabady, A., Demillard, L. J., Yu, W., Hilaire, M. L., Zhang, Y., & Ren, J. T. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114661 · Cited by 55
Calciphylaxis in the current era: emerging 'ironic' features?
Farah, M., Crawford, R. I., Levin, A., & Yan, C. C. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq407 · Cited by 53
Chronic iron overload in rats increases vascular reactivity by increasing oxidative stress and reducing nitric oxide bioavailability
Marques, V. B., Botelho, T., Júnior, R. F. R., Broseghini-Filho, G. B., Rossi, E. M., Graceli, J. B., & dos SANTOS, L. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.034 · Cited by 52
Cerebral blood flow alteration in neuroprotection following cerebral ischaemia
Sutherland, B. A., Papadakis, M., Chen, R., & Buchan, A. M. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.209601 · Cited by 50
Iron overload in nonalcoholic steatohepatitis
Fujita, N., & Takei, Y. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-387042-1.00006-x · Cited by 49
Age-associated Iron Accumulation in Bone: Implications for Postmenopausal Osteoporosis and a New Target for Prevention and Treatment by Chelation
Liu, G., Men, P., KENNER, G. H., & Miller, S. C. (2006) · BioMetals · doi:10.1007/s10534-005-6666-2 · Cited by 50
Impairment of Transendothelial Leukocyte Migration by Iron Complexes
Sengoelge, G., Kletzmayr, J., Ferrara, I., Perschl, A. M., Hörl, W. H., & Sunder–Plassmann, G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000087087.61306.4a · Cited by 50
Vitamin C protects low-density lipoprotein from homocysteine-mediated oxidation
Alul, R. H., Wood, M., Longo, J., Marcotte, A., Campione, A. L., Moore, M. K., & Lynch, S. M. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00028-5 · Cited by 47
Protective effects of an aqueous extract of Welsh onion green leaves on oxidative damage of reactive oxygen and nitrogen species
Wang, B., LIN, S., Hsiao, W.-C., FAN, J., FUH, L., & Duh, P. (2005) · Food Chemistry · doi:10.1016/j.foodchem.2005.05.057 · Cited by 47
Nitric oxide-dependent vasodilation in human subjects
Vita, J. A. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)59183-7 · Cited by 44
Self-citation
Iron overload, oxidative stress and vascular dysfunction: Evidences from clinical studies and animal models
dos SANTOS, L., Bertoli, S. R., Ávila, R. A., & Marques, V. B. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130172 · Cited by 44
Do Hemochromatosis Mutations Protect Against Iron-Mediated Atherogenesis?
Sullivan, J. L. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.906230 · Cited by 43
Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD
Buren, P. N. V., Velez, R. L., Vaziri, N. D., & Zhou, X. J. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-0028-5 · Cited by 42
Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron
Vinchi, F. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8167 · Cited by 46
The Emerging Role of Ferroptosis in Cardiovascular Diseases
Hong, M., Rong, J., Tao, X., & Xu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.822083 · Cited by 41
Stored Iron and Vascular Reactivity
Sullivan, J. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000174124.20147.22 · Cited by 41
Foam cell death induced by 7β-hydroxycholesterol is mediated by labile iron-driven oxidative injury: Mechanisms underlying induction of ferritin in human atheroma
Li, W., Hellsten, A., Xu, L.-H., Zhuang, D., Jansson, K., Brunk, U. T., & Yuan, X. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.006 · Cited by 40
Management of the no-reflow phenomenon
Butler, M. J., Chan, W., Taylor, A. J., Dart, A. M., & Duffy, S. J. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.010 · Cited by 38
Self-citation
ENDOPLASMIC RETICULUM STRESS INVOLVED IN HEART AND LIVER INJURY IN IRON‐LOADED RATS
Lou, L., Geng, B., Chen, Y., Yu, F., Zhao, J., & Tang, C. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05114.x · Cited by 38
Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy
Anderson, T. J., Hubacek, J., Wyse, D. G., & Knudtson, M. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02770-5 · Cited by 38
Hydrogen peroxide restrains endothelium-derived nitric oxide bioactivity—Role for iron-dependent oxidative stress
Thomas, S. R., Schulz, E., & Keaney, J. F. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.012 · Cited by 37
Self-citation
The Statin–Iron Nexus: Anti-Inflammatory Intervention for Arterial Disease Prevention
Zacharski, L. R., DePalma, R. G., Shamayeva, G., & Chow, B. K. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301163 · Cited by 36
Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis
Jin, S., Wang, H., Zhang, X., Song, M., Liu, B., & Sun, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116457 · Cited by 35
Effect of Dexrazoxane on Homocysteine-Induced Endothelial Dysfunction in Normal Subjects
Zheng, H., Dimayuga, C., Hudaihed, A., & Katz, S. D. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000023187.25914.5b · Cited by 33

Authors: Duffy, S. J., Biegelsen, E. S., Holbrook, M., Russell, J. D., Gokce, N., Keaney, J. F., & Vita, J. A.
Affiliations: Boston University (US)
ORCID: Duffy, Stephen J.
Gokce, Noyan
Keaney, John F.
Vita, Joseph A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-06-12
Volume: 103
Issue: 23
Pages: 2799-2804
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.103.23.2799
OpenAlex: W2006984835
Cited by: 271
References: 34
Citations by year: 2026: 4 · 2025: 6 · 2024: 10 · 2023: 10 · 2022: 9 · 2021: 8 · 2020: 10 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 12
FWCI: 12.78
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: American Heart Association
National Institutes of Health (5r01hl052936-04, 5r01hl059346-02, 1r01hl053398-01a1)
Medical Research Council
National Health and Medical Research Council
National Medical Research Council
National Heart, Lung, and Blood Institute (K23 HL 04425, HL59346, HL 53398, HL 55993, P01HL055854, HL-100088, HL58976, R01HL058976, HL-55854, K23HL004425, P50HL055993, HL-52936)
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords: iron chelation, deferoxamine, endothelial dysfunction, coronary artery disease, nitric oxide, endothelium-dependent vasodilation, oxidative stress, hydroxyl radicals, Fenton reaction, atherosclerosis, methacholine responsiveness, forearm resistance vessels, L-NMMA
MeSH terms: Adult, Blood Flow Velocity, Coronary Disease, Deferoxamine, Endothelium, Vascular, Enzyme Inhibitors, Female, Forearm, Humans, Infusions, Intra-Arterial, Iron, Iron Chelating Agents, Male, Middle Aged, Nitroprusside, Plethysmography, Vasodilation, Vasomotor System, Free Radical Scavengers, Methacholine Chloride, Nitric Oxide Synthase, omega-N-Methylarginine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks